Concomitant progressive supranuclear palsy and multiple system atrophy: More than a simple twist of fate?

[1]  P Sandroni,et al.  Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.

[2]  D. Dickson,et al.  Glial cytoplasmic inclusions in neurologically normal elderly: prodromal multiple system atrophy? , 2008, Acta Neuropathologica.

[3]  D. Dickson,et al.  Co-localization of tau and α-synuclein in the olfactory bulb in Alzheimer’s disease with amygdala Lewy bodies , 2008, Acta Neuropathologica.

[4]  J. Trojanowski,et al.  Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy , 2007, Neuropathology and applied neurobiology.

[5]  P. Hartikainen,et al.  Abundant glial alpha-synuclein pathology in a case without overt clinical symptoms. , 2007, Clinical neuropathology.

[6]  A. Lees,et al.  Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. , 2007, Brain : a journal of neurology.

[7]  V. Bonifati.  The pleomorphic pathology of inherited parkinson’s disease: Lessons from LRRK2 , 2006, Current neurology and neuroscience reports.

[8]  A. Lang,et al.  Interface between tauopathies and synucleinopathies: A tale of two proteins , 2006, Annals of neurology.

[9]  D. Dickson,et al.  Coexistence of PSP and MSA: a case report and review of the literature , 2006, Acta Neuropathologica.

[10]  Niall P Quinn,et al.  The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. , 2004, Brain : a journal of neurology.

[11]  M. Horstink,et al.  Striatonigral degeneration with neurofibrillary tangles , 2004, Acta Neuropathologica.

[12]  Keith A. Johnson,et al.  Neuropathology of Cognitively Normal Elderly , 2003, Journal of neuropathology and experimental neurology.

[13]  J. Holton,et al.  Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule‐binding repeat domains as demonstrated by new specific monoclonal antibodies , 2003, Neuropathology and applied neurobiology.

[14]  I. McKeith,et al.  SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders , 2003, Movement disorders : official journal of the Movement Disorder Society.

[15]  J. Trojanowski,et al.  Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein , 2003, Science.

[16]  D. Dickson,et al.  Colocalization of Tau and Alpha‐Synuclein Epitopes in Lewy Bodies , 2003, Journal of neuropathology and experimental neurology.

[17]  Yoav Ben-Shlomo,et al.  The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. , 2002, Brain : a journal of neurology.

[18]  K. Jellinger,et al.  Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease , 2002, Journal of Neural Transmission.

[19]  D. Burn,et al.  The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. , 2001, Brain : a journal of neurology.

[20]  R. Hamilton,et al.  Lewy Bodies in Alzheimer's Disease: A Neuropathological Review of 145 Cases Using α‐Synuclein Immunohistochemistry , 2000, Brain pathology.

[21]  Y Ben-Shlomo,et al.  Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study , 1999, The Lancet.

[22]  I Litvan,et al.  Association of an extended haplotype in the tau gene with progressive supranuclear palsy. , 1999, Human molecular genetics.

[23]  J. Trojanowski,et al.  Antibodies to α‐synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease , 1999, Annals of neurology.

[24]  Hitoshi Takahashi,et al.  α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy , 1998, Neuroscience Letters.

[25]  D. Dickson,et al.  Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson’s disease , 1998, Acta Neuropathologica.

[26]  S. Tsuji,et al.  Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. , 1998, Neuroscience letters.

[27]  I Litvan,et al.  Validity and Reliability of the Preliminary NINDS Neuropathologic Criteria for Progressive Supranuclear Palsy and Related Disorders , 1996, Journal of neuropathology and experimental neurology.

[28]  Peter L. Lantos,et al.  Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome) , 1989, Journal of the Neurological Sciences.

[29]  Y. S. Wang.  [Progressive supranuclear palsy]. , 1989, Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry.

[30]  J. Olszewski,et al.  Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia , 1964 .